Chinese researcher hailed for life-giving leukaemia transplant research
- Huang Xiaojun developed a treatment that greatly expanded the pool of bone marrow donors
- His process has spread throughout China and the world, and recognised by his peers with an award
A Chinese medical professor has been recognised by his international peers for research that increased the survival rate of some leukaemia patients.
Huang Xiaojun, director of the Institute of Haematology at Peking University, was granted the distinguished service award from the Centre for International Blood and Marrow Transplant Research on Friday for developing a series of treatment techniques now known as the “Beijing protocol”, according to state news agency Xinhua.
These kinds of transplants enable patients to draw on a bigger potential pool of donors, such as parents and siblings.
Verneris said the techniques had led to a significant increase in haploidentical transplants.
The techniques were officially named the Beijing protocol in 2016 and have become one of the main methods of such bone marrow transplants, according to the Xinhua report.